Asset Details
Do you wish to reserve the book?
Bone Loss in the HIV-Infected Patient: Evidence, Clinical Implications, and Treatment Strategies
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Bone Loss in the HIV-Infected Patient: Evidence, Clinical Implications, and Treatment Strategies
Do you wish to request the book?
Bone Loss in the HIV-Infected Patient: Evidence, Clinical Implications, and Treatment Strategies
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Bone Loss in the HIV-Infected Patient: Evidence, Clinical Implications, and Treatment Strategies
2012
Overview
Osteoporosis is common in human immunodeficiency virus (HIV)—infected persons. The etiology of osteoporosis in HIV-infected patients is likely multifactorial, involving traditional risk factors such as low body weight, hypogonadism, and smoking, as well as direct effects of chronic HIV infection and antiretroviral therapy. Emerging evidence suggests that the increasing prevalence of osteoporosis in HIV-infected persons translates into a higher risk of fracture, likely leading to excess morbidity and mortality as the HIV-infected population ages. This review addresses the epidemiology of osteoporosis, discusses the causes of low bone mineral density in HIV-infected persons, including the impact of specific antiretroviral therapies, and offers recommendations on screening and treating vitamin D deficiency and osteoporosis.
Publisher
Oxford University Press
Subject
Anti-HIV Agents - adverse effects
/ Anti-HIV Agents - therapeutic use
/ Bone Density Conservation Agents - therapeutic use
/ Bones
/ Diphosphonates - therapeutic use
/ HIV
/ HIV Infections - complications
/ HIV Infections - drug therapy
/ Humans
/ Men
/ Osteoporosis - prevention & control
